Tenascin-C is a matricellular protein upregulated during cardiac remodeling that serves as a potential biomarker for assessing prognosis and guiding therapy in inflammatory heart diseases.
No takes yet. Share an insight, caveat, or question.
TNC re-expression marks pathological cardiac remodeling; leaves open its value as biomarker or target pending validation.
Imanaka‐Yoshida et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: